Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 5261 of 5804
-
French researchers dive into gambling addiction: first detailed look at At-Risk players
Knowledge-focused UNKNOWN_STATUSInternational surveys about pathological gambling estimate that there are about 1 to 3 per cent of gamblers who develop a pathological behavior about gamble.In France, pathological gambling is not a priority of public health, in contrast with other addictive disorders, like alcoh…
Sponsor: Nantes University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:03 UTC
-
Desperate patient gets own stem cells for rare nerve disease
Symptom relief NO_LONGER_AVAILABLEThis Individual Patient Expanded Access IND has been created as requested by an 58-year-old man who suffers from Polyneuropathy due to Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal gammopathy, and Skin abnormalities (POEMS) Syndrome. The patient will receive 8 infusion…
Sponsor: Hope Biosciences Research Foundation • Aim: Symptom relief
Last updated Jun 27, 2026 07:52 UTC
-
Experimental drug axatilimab made available for one patient with chronic GVHD
Disease control APPROVED_FOR_MARKETINGThis program is being offered on a patient by patient basis and will require company, Institutional Review Board/Independent Ethics Committee and Single Patient IND approval.
Sponsor: Incyte Corporation • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Desperate for relief: one patient gets experimental stem cell infusions for chronic pain
Symptom relief NO_LONGER_AVAILABLEThis is an Individual Patient Expanded Access IND providing multiple administrations of HBadMSCs for the treatment of Chronic Musculoskeletal Pain. The study duration is approximately 32 weeks, during that time the study subject will complete 1 screening visit, 6 infusion visits,…
Sponsor: Hope Biosciences Research Foundation • Aim: Symptom relief
Last updated Jun 27, 2026 07:52 UTC
-
Last-Resort access to ceritinib for ALK-Positive cancer patients
Disease control NO_LONGER_AVAILABLEThe purpose of this registration is to list Managed Access Programs (MAPs) related to LDK378, Ceritinib.
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Second-Chance stem cell therapy for blood cancer patients
Disease control AVAILABLEThis study is not designed to test a hypothesis; rather, this study will provide patients with access to Orca-T if the commercial Orca-T product produced for them is deemed out of specification (OOS). Serious adverse events (SAEs) occurring during the safety reporting period (def…
Sponsor: Orca Biosystems, Inc. • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Early access program offers experimental spinal cord injury drug
Disease control NO_LONGER_AVAILABLEThis is an expanded access program (EAP) for eligible participants. This program is designed to provide access to Elezanumab prior to approval by the local regulatory agency. Availability will depend on territory eligibility. A medical doctor must decide whether the potential ben…
Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Early access to experimental AML drug ABBV-787 now available for some patients
Disease control NO_LONGER_AVAILABLEThis is an expanded access program (EAP) for eligible participants. This program is designed to provide access to ABBV-787 prior to approval by the local regulatory agency. Availability will depend on territory eligibility. A medical doctor must decide whether the potential benef…
Sponsor: AbbVie • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
What do families think about genetic testing? new study seeks answers
Knowledge-focused CompletedAfter the use of DNA chips for diagnostic purposes, high-throughput sequencing (HTS) is transforming the field of developmental diseases, from fundamental research to care. Nonetheless, before HTS can be transferred to everyday clinical practice, in particular for expert diagnosi…
Phase: NA • Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:02 UTC
-
Free drug access for Parkinson's patients with specific gene mutation
Disease control AVAILABLEThis Program is designed to provide continued access BIA 28-6156, free and compassionately for an eligible patient previously enrolled in the BIA 28-6156-201 (ACTIVATE) clinical study and that had completed the study.
Sponsor: Bial R&D Investments, S.A. • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New brain scan agent helps tell tumor from treatment side effects
Diagnosis NO_LONGER_AVAILABLEThe aim of this Expanded Access Program (EAP) is to enable the use of 18F-Floretyrosine with positron emission tomography/computed tomography (PET/CT) or positron emission tomography/magnetic resonance (PET/MR) imaging to noninvasively detect tumor burden or treatment related cha…
Sponsor: Telix Pharmaceuticals (Innovations) Pty Limited • Aim: Diagnosis
Last updated Jun 27, 2026 13:00 UTC
-
Gene therapy RGX-202 made available for single patients in need
Disease control TEMPORARILY_NOT_AVAILABLEProvide single patient expanded access to RGX-202 for eligible patients
Sponsor: REGENXBIO Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Hidden danger: muscle loss strikes many with obesity
Knowledge-focused Recruiting nowSarcopenia, a condition where individuals lose muscle mass and strength, is associated with poorer health and function. While aging is a well-known cause of sarcopenia, obesity is increasingly recognised as a significant factor. When sarcopenia and obesity occur together, it can …
Sponsor: Singapore General Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
New MRI method aims to spot kidney trouble early in metabolic syndrome
Knowledge-focused CompletedMetabolic syndrome is a collection of conditions that affect at least three of the following five criteria: abdominal obesity, high blood pressure, high fasting glucose levels, high triglyceride levels, and low levels of high-density lipoprotein (HDL) cholesterol. Chronic kidney …
Phase: EARLY_PHASE1 • Sponsor: University of Zurich • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:03 UTC
-
ER weight guess? 3D camera may cut drug errors
Knowledge-focused TerminatedThe goal of this randomized controlled clinical trial is to compare standard methods of weight estimation and drug dose calculations against weight estimates and dose calculations using a 3D camera weight estimation system in critically ill or injured cohorts of patients presenti…
Phase: NA • Sponsor: Florida Atlantic University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:05 UTC
-
Can temperature mess with your breathing and brain? new study investigates
Knowledge-focused Not yet recruitingWarfighters are frequently exposed to environments and life-support systems that increase breathing resistance and the work of breathing (WOB), such as aircraft on-board oxygen generation systems and underwater breathing apparatuses. Elevated WOB increases the perception of breat…
Phase: NA • Sponsor: Indiana University • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:01 UTC
-
New MRI software aims to cut scan time and noise
Knowledge-focused Not yet recruitingThe goal of this clinical trial is to find out if new Magnetic Resonance Imaging (MRI) computer software will: * help make scans and exams faster * reduce artifacts * make MRI easier to understand * allow technicians to focus more on the participant and less on the scanner Part…
Phase: NA • Sponsor: University of Wisconsin, Madison • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
Iron pills may boost exercise in thin air, tiny study hints
Symptom relief Not yet recruitingThe purpose of this study is to determine if taking iron supplement pills improves exercise performance in low-oxygen conditions.
Phase: EARLY_PHASE1 • Sponsor: University of Colorado, Denver • Aim: Symptom relief
Last updated Jun 27, 2026 12:25 UTC
-
Timing aspirin might counteract blood pressure side effect of common painkiller
Knowledge-focused Not yet recruitingTo determine whether timed administration of aspirin ameliorates the effects of celecoxib on blood pressure.
Phase: EARLY_PHASE1 • Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Study to uncover hidden social roots of poor oral health in egyptian women
Knowledge-focused Not yet recruitingGlobally, there is substantial evidence indicating that low household income, lack of education, poor living conditions and inadequate psycho-social social support are potential risk factors for morbidity and premature death. Despite that, worldwide, there is scarcity in evidence…
Sponsor: Misr International University • Aim: Knowledge-focused
Last updated Jul 18, 2026 00:00 UTC